The Food and Drug Administration is warning consumers that two lots of Tydemy, a birth control pill, may have reduced effectiveness due to decreased levels of ascorbic acid in the product.
The affected lots of this oral contraceptive manufactured by Lupin Pharmaceuticals were distributed in the U.S. from June 3, 2022, to May 31, 2023.
“This potential reduction in the effectiveness of this oral contraceptive could result in an unexpected pregnancy,” according to the FDA. However, to date, officials have not received any reports of adverse events related to using this product.
On July 29 Lupin notified consumers about its voluntary recall of the two lots of Tydemy for patients.
Patients should immediately contact their healthcare provider for advice regarding an alternative contraceptive method if they have this prescription.
FDA encourages health care professionals and patients to report adverse events or quality problems with these or any medications to the agency’s MedWatch Adverse Event Reporting program.
This is a developing story. Check back for updates as more information becomes available.
Download the FREE Boston 25 News app for breaking news alerts.
Follow Boston 25 News on Facebook and Twitter. | Watch Boston 25 News NOW
©2023 Cox Media Group
